231 related articles for article (PubMed ID: 26560987)
1. Effects of low-dose morphine on perceived sleep quality in patients with refractory breathlessness: A hypothesis generating study.
Martins RT; Currow DC; Abernethy AP; Johnson MJ; Toson B; Eckert DJ
Respirology; 2016 Feb; 21(2):386-91. PubMed ID: 26560987
[TBL] [Abstract][Full Text] [Related]
2. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea.
Abernethy AP; Currow DC; Frith P; Fazekas BS; McHugh A; Bui C
BMJ; 2003 Sep; 327(7414):523-8. PubMed ID: 12958109
[TBL] [Abstract][Full Text] [Related]
3. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.
Verberkt CA; van den Beuken-van Everdingen MHJ; Schols JMGA; Hameleers N; Wouters EFM; Janssen DJA
JAMA Intern Med; 2020 Oct; 180(10):1306-1314. PubMed ID: 32804188
[TBL] [Abstract][Full Text] [Related]
4. Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial.
Currow D; Louw S; McCloud P; Fazekas B; Plummer J; McDonald CF; Agar M; Clark K; McCaffrey N; Ekström MP;
Thorax; 2020 Jan; 75(1):50-56. PubMed ID: 31558624
[TBL] [Abstract][Full Text] [Related]
5. Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial.
Ekström M; Ferreira D; Chang S; Louw S; Johnson MJ; Eckert DJ; Fazekas B; Clark KJ; Agar MR; Currow DC;
JAMA; 2022 Nov; 328(20):2022-2032. PubMed ID: 36413230
[TBL] [Abstract][Full Text] [Related]
6. Extended-Release Morphine for Chronic Breathlessness in Pulmonary Arterial Hypertension-A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Ferreira DH; Ekström M; Sajkov D; Vandersman Z; Eckert DJ; Currow DC
J Pain Symptom Manage; 2018 Oct; 56(4):483-492. PubMed ID: 30031217
[TBL] [Abstract][Full Text] [Related]
7. A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol.
Currow D; Watts GJ; Johnson M; McDonald CF; Miners JO; Somogyi AA; Denehy L; McCaffrey N; Eckert DJ; McCloud P; Louw S; Lam L; Greene A; Fazekas B; Clark KC; Fong K; Agar MR; Joshi R; Kilbreath S; Ferreira D; Ekström M;
BMJ Open; 2017 Jul; 7(7):e018100. PubMed ID: 28716797
[TBL] [Abstract][Full Text] [Related]
8. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
[TBL] [Abstract][Full Text] [Related]
9. Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness--An Exploratory Study.
Ferreira DH; Silva JP; Quinn S; Abernethy AP; Johnson MJ; Oxberry SG; Currow DC
J Pain Symptom Manage; 2016 Feb; 51(2):247-54. PubMed ID: 26598037
[TBL] [Abstract][Full Text] [Related]
10. Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trial.
Johnson MJ; Cockayne S; Currow DC; Bell K; Hicks K; Fairhurst C; Gabe R; Torgerson D; Jefferson L; Oxberry S; Ghosh J; Hogg KJ; Murphy J; Allgar V; Cleland JGF; Clark AL
ESC Heart Fail; 2019 Dec; 6(6):1149-1160. PubMed ID: 31389157
[TBL] [Abstract][Full Text] [Related]
11. The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease.
Poole PJ; Veale AG; Black PN
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1877-80. PubMed ID: 9620921
[TBL] [Abstract][Full Text] [Related]
12. Patients' and caregivers' experiences of driving with chronic breathlessness before and after regular low-dose sustained-release morphine: A qualitative study.
Ferreira DH; Boland JW; Kochovska S; Honson A; Phillips JL; Currow DC
Palliat Med; 2020 Sep; 34(8):1078-1087. PubMed ID: 32519599
[TBL] [Abstract][Full Text] [Related]
13. The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.
Allcroft P; Margitanovic V; Greene A; Agar MR; Clark K; Abernethy AP; Currow DC
J Palliat Med; 2013 Jul; 16(7):741-4. PubMed ID: 23597092
[TBL] [Abstract][Full Text] [Related]
14. Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial.
Abdallah SJ; Wilkinson-Maitland C; Saad N; Li PZ; Smith BM; Bourbeau J; Jensen D
Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29051274
[TBL] [Abstract][Full Text] [Related]
15. The impact of regular, low-dose, sustained-release morphine for chronic breathlessness on caregiver burden: An exploratory analysis of the BEAMS trial.
Kochovska S; Ferreira D; Chang S; Luckett T; Roydhouse J; Ekström M; Currow DC
Palliat Med; 2024 Jan; 38(1):156-162. PubMed ID: 37978419
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of sustained-release morphine for refractory breathlessness in COPD: A randomized clinical trial.
Verberkt CA; van den Beuken-van Everdingen MHJ; Dirksen CD; Schols JMGA; Wouters EFM; Janssen DJA
Respir Med; 2021 Apr; 179():106330. PubMed ID: 33611087
[TBL] [Abstract][Full Text] [Related]
17. Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial.
Oxberry SG; Torgerson DJ; Bland JM; Clark AL; Cleland JG; Johnson MJ
Eur J Heart Fail; 2011 Sep; 13(9):1006-12. PubMed ID: 21712288
[TBL] [Abstract][Full Text] [Related]
18. Testosterone Levels in People Taking Regular Low-Dose Sustained-Release Morphine for Persisting Breathlessness: An Exploratory Study.
Ferreira DH; Ekström M; Fazekas B; Currow DC
J Palliat Med; 2023 Mar; 26(3):402-405. PubMed ID: 36394475
[No Abstract] [Full Text] [Related]
19. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study.
Currow DC; McDonald C; Oaten S; Kenny B; Allcroft P; Frith P; Briffa M; Johnson MJ; Abernethy AP
J Pain Symptom Manage; 2011 Sep; 42(3):388-99. PubMed ID: 21458217
[TBL] [Abstract][Full Text] [Related]
20. Patients' and their caregivers' experiences with regular, low-dose, sustained-release morphine for chronic breathlessness associated with COPD: a qualitative study.
Ferreira D; Kochovska S; Honson A; Phillips J; Currow D
BMJ Open Respir Res; 2022 May; 9(1):. PubMed ID: 35606022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
